PRKCE and breast cancer: Our laboratory demonstrated that inhibition of PKCε in MDA-MB231 cells, a highly metastatic breast cancer cell line with elevated PKCε levels, was sufficient to dramatically decrease in vivo tumor growth and reduce the incidence of lung metastasis [7].